Leader in Cancer Research named CEO of ZIOPHARM NEW YORK, NY MAY 1 - Privately-held ZIOPHARM, Inc. announced it named Jonathan J. Lewis, MD, PhD, a founder of the company, to the position of chief executive officer. Dr. Lewis has both academic expertise and industry recognition in product
ZIOPHARM Forms Board of Directors NEW HAVEN, CT SEPT 15 - Privately held ZIOPHARM, Inc., a developer of cancer drugs, announced it named eight individuals with diverse backgrounds in medicine, pharmaceutical and biotechnology management, legal and government affairs, and finance and communications
